We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy

Unwrap our new Directory

FABP5 Inhibitor

Bio-Pharma

Artelo Biosciences Reports Positive ART26.12 Pain Data

SOLANA BEACH, Calif., July 1, 2026 Artelo Biosciences, Inc. announced positive preclinical data demonstrating that its investigational drug candidate...

By cGxPwire Editor
July 6, 2026

Recent Posts

01

Bio-Pharma

Roivant and Pulmovant to Unveil Topline Mosliciguat Results in PH-ILD
September 7, 2026
02

Bio-Pharma

AstraZeneca Wins U.S. Approval for ETCAMAH in Breast Cancer
September 7, 2026
03

Bio-Pharma

Novartis and Ionis Pharmaceuticals Face Setback in Pelacarsen Trial
September 7, 2026
04

MedTech

Modular Medical Expands Pivot Pump Access Through U.S. PBM Contract
September 7, 2026
05

Bio-Pharma

Biogen Reports Long-Term Zorevunersen Data in Dravet Syndrome
September 7, 2026